NEKTAR

Serial Number 97725910
732

Registration Progress

Application Filed
Dec 20, 2022
Under Examination
Jan 2, 2024
Approved for Publication
Nov 7, 2023
Published for Opposition
Nov 7, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Jan 02, 2026 156 days

Trademark Image

NEKTAR

Basic Information

Serial Number
97725910
Filing Date
December 20, 2022
Published for Opposition
November 7, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
732
Status Date
May 1, 2025
Application
Pending
Classes
005

Rights Holder

Nektar Therapeutics

03
Address
455 Mission Bay Boulevard South, Ste 100
San Francisco, CA 94158

Ownership History

Nektar Therapeutics

Original Applicant
03
San Francisco, CA

Nektar Therapeutics

Owner at Publication
03
San Francisco, CA

Legal Representation

Attorney
Jennifer D. Arkowitz

USPTO Deadlines

Next Deadline
156 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
January 02, 2026
Extension Available
Until January 02, 2025

Application History

26 events
Date Code Type Description Documents
May 2, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 1, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
May 1, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 30, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 10, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 10, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 29, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 29, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 28, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 2, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 4, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 29, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 28, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 28, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 21, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 21, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 21, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 20, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 23, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance for the treatment of medical conditions in the nature of cancer; pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance for the treatment of medical conditions in the nature of immune system related diseases and disorders

Additional Information

Design Mark
The mark consists of NEKTAR in stylized text.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005